Abstract:Background: Obesity is a global epidemic with significant health risks, including type 2 diabetes and cardiovascular diseases. Increasing white adipose tissue (WAT) browning has shown metabolic benefits in both animal models and humans. Long non-coding RNAs (lncRNAs), have been implicated in various diseases, including metabolic disorders. Growth arrest-specific 5 (GAS5), a tumor suppressor lncRNA decreased in type 2 diabetic patients, has been found to be involved in adipocyte differentiation, however, the role of GAS5 in WAT browning has not yet been established. We hypothesized that in the presence of an adipose tissue browning stimuli, GAS5 promotes WAT browning Methods: In vitro approaches through knocking down or overexpressing GAS5 were used to determine its role in regulating thermogenic genes and thermogenesis. To test the role of GAS5 in adipose tissue browning in vivo , adenovirus AAV8 expressing GAS5 was administered specifically in epidydimal adipose tissues followed by the treatment of browning stimuli CL-316,243. Results: Knockdown of GAS5 increased Smad3 phosphorylation, which was blocked by Smad3 inhibitor, SIS3. Conversely, overexpression of GAS5 inhibited Smad3 phosphorylation. On the other hand, Smad3 overexpression blocked the stimulatory effects of GAS5 on the expression of thermogenic genes PGC-1α and UCP1. Moreover, overexpression of GAS5 inhibited, while knockdown of GAS5 enhanced, Smad3 nuclear translocation and tis binding to PGC-1α promoter. In vivo experiments with GAS5 overexpression in epididymal adipose tissues revealed that GAS5 promotes CL-316,243-induced WAT browning in mice. Conclusions: Our study demonstrates that GAS5 promotes WAT browning by suppressing Smad3 signaling, which in turn increases thermogenesis via stimulating PGC-1α and UCP1 expression. These findings establish GAS5 as a novel regulator of WAT browning with potential implications for mitigating obesity and associated metabolic disorders.

Epidermis-Activated Gasdermin-A3 Enhances Thermogenesis of Brown Adipose Tissue Through IL-6/Stat3 Signaling.

Defective Brown Adipose Tissue Thermogenesis and Impaired Glucose Metabolism in Mice Lacking Letmd1.

Mir-133A Regulates Adipocyte Browning in Vivo.

Loss of Conserved Gsdma3 Self-Regulation Causes Autophagy and Cell Death.

Depletion of Gsdma1/2/3 alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR-Stat3/Akt pathway

Gasdermin D Deficiency Does Not Protect Mice from High-Fat Diet-Induced Glucose Intolerance and Adipose Tissue Inflammation

Gasdermin A Is Required for Epidermal Cornification during Skin Barrier Regeneration and in an Atopic Dermatitis-Like Model

BAF60a Orchestrates Thermogenic Chromatin Accessibility in Brown Fat

BAF60a Deficiency Uncouples Chromatin Accessibility and Cold Sensitivity from White Fat Browning.

Genetic and Pharmacological Targeting of GSDMD Ameliorates Systemic Inflammation in Macrophage Activation Syndrome

Ablation of ORMDL3 impairs adipose tissue thermogenesis and insulin sensitivity by increasing ceramide generation

Roles of GasderminA3 in Catagen-Telogen Transition During Hair Cycling

Inhibition of gasdermin D (GSDMD) as a promising therapeutic approach for atopic dermatitis

Gsdma3 gene is needed for the induction of apoptosis-driven catagen during mouse hair follicle cycle

Abstract 19030: Growth Arrest-Specific 5, a Novel Regulator of Adipose Tissue Browning

Gasdermin E promotes translocation of p65 and c-jun into nucleus in keratinocytes for progression of psoriatic skin inflammation

Dnmt3b Deficiency in Myf5+-Brown Fat Precursor Cells Promotes Obesity in Female Mice

PGE2-EP3 Axis Promotes Brown Adipose Tissue Formation Through Stabilization of WTAP RNA Methyltransferase

HDAC3-Selective Inhibition Activates Brown and Beige Fat Through PRDM16

Gasdermin D-Mediated Pyroptosis Promotes the Development of Atherosclerosis

Epidermal keratinocyte-specific STAT3 deficiency aggravated atopic dermatitis-like skin inflammation in mice through TSLP upregulation